Labocanna Spolka Akcyjna Logo

Labocanna Spolka Akcyjna

Cultivates, produces, and distributes hemp products for food and medical use.

LCN | WAR

Overview

Corporate Details

ISIN(s):
PLCCTLS00017 (+1 more)
LEI:
259400GAPNZTGIR9PK55
Country:
Poland
Address:
KOSZALIN MIESZKA I 49, 75-129 KOSZALIN

Description

Labocanna Spolka Akcyjna is a company engaged in the cultivation, production, and distribution of hemp products. Its offerings include food and medical hemp-derived items. The company's primary strategic goal is to launch the production of medical marijuana for patients and clinical use, with a focus on indoor cultivation methods. Labocanna is pursuing collaborations with research institutes to produce pharmaceutical raw materials and is actively developing new compounds and mixtures based on cannabinoids such as CBD, CBG, and CBC. The company plans to manage 500 hectares of cultivation fields through acquisitions and contracting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-22 15:55
Sprzedaż akcji w Vinci Gen S.A. - Content (PL)
Polish 797 bytes
2024-02-09 17:33
Zawarcie przedwstępnej umowy na import marihuany medycznej - Content (PL)
Polish 2.3 KB
2024-02-09 08:40
Rozwiązanie Umowy Inwestycyjnej w sprawie połączenia ze spółką Foxbuy.com S.A. …
Polish 806 bytes
2024-01-24 17:56
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
Polish 810 bytes
2024-01-18 08:46
Otrzymanie pisma z Instytutu Weterynaryjnego - Państwowego Instytutu Badawczego…
Polish 874 bytes
2024-01-02 17:24
Wygaśnięcie umowy o zachowaniu poufności - Content (PL)
Polish 654 bytes
2023-12-28 17:28
Formularz dla pełnomocnika
Polish 133.8 KB
2023-12-28 17:28
Proponowane zmiany statutu Labocanna S.A.
Polish 183.6 KB
2023-12-28 17:28
Projekty uchwał na NWZA Labocanna S.A.
Polish 221.4 KB
2023-12-28 17:28
Ogłoszenie o NWZA Labocanna S.A.
Polish 99.3 KB
2023-12-28 17:28
ogłoszenie o zwołaniu NWZ na dzień 24 stycznia 2024 r. wraz z projektami uchwał…
Polish 469 bytes
2023-12-28 16:49
Lista akcjonariuszy, którzy wzięli udział w Walnym Zgromadzeniu oraz mieli co n…
Polish 603 bytes
2023-12-20 18:02
Założenie spółki zależnej - Content (PL)
Polish 1.0 KB
2023-12-01 15:37
Formularz dla pełnomocnika na NWZA
Polish 132.6 KB
2023-12-01 15:37
Proponowane zmiany statutu na NWZA
Polish 204.9 KB

Automate Your Workflow. Get a real-time feed of all Labocanna Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Labocanna Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Labocanna Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.